Iqvia wins tender to provide laboratory system for Danish National Genome Center

The National Genome Center in Denmark has entered an agreement with Iqvia to supply a new laboratory system, the latter reports in a statement.

Photo: Gregers Tycho/Ritzau Scanpix

After a tender process lasting for more than a year, Iqvia has been chosen to deliver a new laboratory system to the Danish National Genome Center (NGC), the company writes in a statement.

The deal concerns the development, delivery and implementation of a laboratory information system. While the system itself will be developed by the company's partner Sapio Sciences, Iqvia will be in charge of providing consulting services in a contract period of four years, the statement reads.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

"Real world" patient data documents the long-term effects of ALK vaccines

In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers. 

Further reading

Related articles

Latest news

See all jobs